FDA device listing

CareSens N Mini Blood Glucose Monitoring System,ReliOn Premier COMPACT Blood Glucose Monitoring System

FDA device listing 1731552469 · i-SENS, Inc.

Key facts

Proprietary names CareSens N Mini Blood Glucose Monitoring System,ReliOn Premier COMPACT Blood Glucose Monitoring System
Owner/operator i-SENS, Inc.
Owner/operator number 9083763
Premarket submissions K120759
Product codes CGA, JJX, NBW
Device names CGA - Glucose Oxidase, Glucose, JJX - Single (Specified) Analyte Controls (Assayed And Unassayed), NBW - System, Test, Blood Glucose, Over The Counter
Device class Class I, Class II
Classification regulations (21 CFR) 862.1345, 862.1660
Review panels Clinical Chemistry
Registered establishments I-SENS, INC., i-SENS Songdo Factory, I-SENS Songdo Factory 2, i-SENS Wonju Factory
Establishment registrations 3005621222, 3007382160, 3011213605, 3030186688
FEI numbers 3005621222, 3007382160, 3011213605, 3030186688
Establishment operations Manufacturer, Specification Developer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 10–99 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings